Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Annals of Hematology|April 23, 2014
Is it really possible to cure hairy cell leukemia patients only with frontline therapy?Pier Luigi Zinzani, Vittorio Stefoni, Alessandro Broccoli, et al.
Hematological Oncology|August 6, 2024
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors-The MicroLinf StudyBeatrice Casadei, Gabriele Conti, Monica Barone, et al.
Seminars in Nuclear Medicine|December 15, 2022
PET/CT in Non-Hodgkin Lymphoma: An UpdateLucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Hematological Oncology|July 3, 2014
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patientsPier Luigi Zinzani, Cinzia Pellegrini, Alessandro Broccoli, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2026
The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysisDomenico Albano, Stephane Chauvie, Alessio Rizzo, et al.
The Oncologist|May 30, 2014
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphomaCinzia Pellegrini, Lisa Argnani, Alessandro Broccoli, et al.
Hematological Oncology|September 27, 2014
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patientsPier Luigi Zinzani, Alessandro Broccoli, Beatrice Casadei, et al.
BMC Cancer|November 11, 2015
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experienceEnrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, et al.
BMC Cancer|April 19, 2017
The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patientsAlessandro Broccoli, Beatrice Casadei, Vittorio Stefoni, et al.
Pageof 10